Skip to search.
 TSX Down 0.53% TSX Ventures Down 0.63%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqCM
2.04 Down 0.08(3.77%) Sep 26, 3:59PM EDT
Prev Close:2.12
Open:2.13
Bid:N/A
Ask:2.68 x 200
1y Target Est:7.33
Beta:2.89012
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:2.02 - 2.14
52wk Range:1.81 - 6.45
Volume:74,956
Avg Vol (3m):144,614
Market Cap:41.80M
P/E (ttm):N/A
EPS (ttm):-1.06
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CYTXDown 3.77%41.80M
BAXDown 0.61%25.67B
OSIRDown 1.88%161.58M
ASTM 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.29
Quarterly EPS Est (Sep-16) :-0.24
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a biotechnology company, develops cellular therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, incl... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback